When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Technology Letter March 11, 2020 Fiat Lux Featured Trade: (THE BEST LEAPS IN MID-SIZED TECH) (TWTR), (EBAY)
Successful investors rarely disclose their modus operandi. The truth is that success comes in all shapes and sizes. Many take the volatility index and aggressively short it until death hoping to avoid the “big one” that wipes them out. Picking up pennies in front of the steam roller on steroids works until it doesn’t. Conversely,
“If you're gonna make connections which are innovative... you have to not have the same bag of experiences as everyone else does.” – Said Co-Founder of Apple Steve Jobs
While the Diary of a Mad Hedge Fund Trader focuses on investment over a one week to a six-month time frame, Mad Day Trader, provided by Bill Davis, will exploit money-making opportunities over a brief ten minute to three-day window. It is ideally suited for day traders, but can also be used by long-term investors to improve market timing for entry and exit points.
Global Market Comments March 11, 2020 Fiat Lux Featured Trade: (A NOTE ON ASSIGNED OPTIONS, OR OPTIONS CALLED AWAY), (AAPL), (BA), (UAL), (CCL), (WYNN), (FB)
“At some point, all the money that has been parked in bonds and money market funds over the last five years will go into equities,” said Julian Emanuel of investment bank BTIG.
ET, of course, sold off with the crash of oil yesterday. It is trading under its lower band on its daily & 60 minute chart. This tells me how oversold the stock is. To me, ET is not a true energy play, even though it is in the energy field. It provides the pipe lines
Mad Hedge Biotech & Healthcare Letter March 10, 2020 Fiat Lux Featured Trade: (A NEW TECHNOLOGY TO EDIT GENES HITS THE MARKET) (MRNA), (GILD)
The biotechnology market is estimated to surge over $775 billion by 2024 as experts in this sector continue to discover cutting-edge treatments for thousands of previously incurable diseases. While gene-editing therapies have been dominating the rare disease field in the past years, Moderna Inc (MRNA) has been working on a novel but supposedly more effective